Merck, Eisai detail Keytruda and Lenvima’s endometrial cancer win in confirmatory study

Merck, Eisai detail Keytruda and Lenvima’s endometrial cancer win in confirmatory study
aliu
Fri, 03/19/2021 – 11:26